Champions Oncology (CSBR) Receivables - Net (2016 - 2026)
Champions Oncology (CSBR) has 15 years of Receivables - Net data on record, last reported at $5.4 million in Q4 2025.
- For Q4 2025, Receivables - Net rose 10.79% year-over-year to $5.4 million; the TTM value through Oct 2025 reached $5.4 million, up 10.79%, while the annual FY2025 figure was $11.2 million, 17.61% up from the prior year.
- Receivables - Net reached $5.4 million in Q4 2025 per CSBR's latest filing, down from $9.5 million in the prior quarter.
- Across five years, Receivables - Net topped out at $15.8 million in Q1 2025 and bottomed at $4.9 million in Q4 2024.
- Average Receivables - Net over 5 years is $8.5 million, with a median of $8.8 million recorded in 2023.
- Peak YoY movement for Receivables - Net: surged 110.19% in 2021, then tumbled 36.92% in 2024.
- A 5-year view of Receivables - Net shows it stood at $8.6 million in 2021, then rose by 4.11% to $9.0 million in 2022, then decreased by 14.44% to $7.7 million in 2023, then crashed by 36.92% to $4.9 million in 2024, then rose by 10.79% to $5.4 million in 2025.
- Per Business Quant database, its latest 3 readings for Receivables - Net were $5.4 million in Q4 2025, $9.5 million in Q3 2025, and $11.2 million in Q2 2025.